YC W18Inactive
Correlia Biosystems
Next-gen blood testing to provide 1000x more data to pharma companies
About
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
Founders
- Akwasi Apori
- Kursad Araz
- Samuel Tia
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Correlia Biosystems.
See family office activityIndustry & Focus
HealthcareDiagnosticsHardwareLab-on-a-chipMicrofluidics